Europe Multiple Myeloma Market and Competitive Landscape - 2017

  • ID: 4377356
  • Report
  • Region: Europe
  • Fore Pharma
1 of 3
The latest research, Europe Multiple Myeloma Market and Competitive Landscape - 2017, provides comprehensive insights into Multiple Myeloma pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Multiple Myeloma market size and drug sales. This research also provides insights into Multiple Myeloma epidemiology and late stage pipeline.

The report is classified into nine sections - Multiple Myeloma overview with definitions, symptoms, etiology, diagnosis, treatment options; Multiple Myeloma pipeline insights covering late stage clinical trials pipeline; Multiple Myeloma prevalence trends by countries; Multiple Myeloma market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes EU5 countries - Germany, France, Italy, Spain, UK, Europe.

Research Scope:
  • Multiple Myeloma pipeline: Find out the drugs in clinical trials for Multiple Myeloma by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
  • Multiple Myeloma epidemiology: Find out the prevalence of Multiple Myeloma by countries - Europe, Germany, France, Italy, Spain, UK, Japan; prevalence forecast to 2025
  • Multiple Myeloma products: Identify key products marketed and prescribed for Multiple Myeloma by brand name, by molecule, by company, by branded / generic, by countries - Europe, Germany, France, Italy, Spain, UK, Japan
  • Multiple Myeloma market size: Find out the market size for Multiple Myeloma drugs by countries - Europe, Germany, France, Italy, Spain, UK, Japan; Find out how the market advanced from 2012
  • Multiple Myeloma drug sales: Find out the sales of Multiple Myeloma drugs by countries - Europe, Germany, France, Italy, Spain, UK
  • Multiple Myeloma drugs sales forecast: Sales forecast for Multiple Myeloma drugs to 2021 by countries - Europe, Germany, France, Italy, Spain, UK, Japan
  • Multiple Myeloma market share analysis: Find out the market shares of Multiple Myeloma drugs and outlook by countries - Europe, Germany, France, Italy, Spain, UK, Japan
Benefits of this Research: The research helps executives to
  • Evaluate commercial market opportunities for Multiple Myeloma drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in Multiple Myeloma market
  • Develop in-depth knowledge of competition and markets
  • Analyze sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track market trends and analyze key events in Multiple Myeloma market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies


This report will take 1-2 business days to deliver.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. Multiple Myeloma: Disease Overview
1.1. Multiple Myeloma Symptoms
1.2. Multiple Myeloma Etiology
1.3. Multiple Myeloma Diagnosis
1.4. Multiple Myeloma Treatment Options

2. Multiple Myeloma Pipeline Insights
2.1. Multiple Myeloma Phase 3 Clinical Trials
2.2. Multiple Myeloma Phase 2 Clinical Trials
2.3. Multiple Myeloma Phase 1 Clinical Trials

3. Multiple Myeloma Epidemiology Analysis

4. Germany Multiple Myeloma Market Insights
4.1. Marketed Products for Multiple Myeloma in Germany
4.2. Germany Multiple Myeloma Market Size & Forecast
4.3. Germany Multiple Myeloma Product Sales Forecast
4.4. Germany Multiple Myeloma Market Share Analysis

5. France Multiple Myeloma Market Insights
5.1. Marketed Products for Multiple Myeloma in France
5.2. France Multiple Myeloma Market Size & Forecast
5.3. France Multiple Myeloma Product Sales Forecast
5.4. France Multiple Myeloma Market Share Analysis

6. Italy Multiple Myeloma Market Insights
6.1. Marketed Products for Multiple Myeloma in Italy
6.2. Italy Multiple Myeloma Market Size & Forecast
6.3. Italy Multiple Myeloma Product Sales Forecast
6.4. Italy Multiple Myeloma Market Share Analysis

7. Spain Multiple Myeloma Market Insights
7.1. Marketed Products for Multiple Myeloma in Spain
7.2. Spain Multiple Myeloma Market Size & Forecast
7.3. Spain Multiple Myeloma Product Sales Forecast
7.4. Spain Multiple Myeloma Market Share Analysis

8. UK Multiple Myeloma Market Insights
8.1. Marketed Products for Multiple Myeloma in UK
8.2. UK Multiple Myeloma Market Size & Forecast
8.3. UK Multiple Myeloma Product Sales Forecast
8.4. UK Multiple Myeloma Market Share Analysis

9. Europe Multiple Myeloma Market Insights
9.1. Europe Multiple Myeloma Market Size & Forecast
9.2. Europe Multiple Myeloma Product Sales Forecast
9.3. Europe Multiple Myeloma Market Share Analysis

10. Research Methodology

List of Tables:
Table 1: Multiple Myeloma Phase 3 Clinical Trials, Global, 2017
Table 2: Multiple Myeloma Phase 2 Clinical Trials, Global, 2017
Table 3: Multiple Myeloma Phase 1 Clinical Trials, Global, 2017
Table 4: Multiple Myeloma Prevalence by EU5 Countries, 2012 - 2021
Table 5: Marketed Products for Multiple Myeloma in Germany, 2017
Table 6: Germany Multiple Myeloma Market Size & Forecast ($mn), 2012 - 2021
Table 7: Germany Multiple Myeloma Product Sales ($mn), 2012 - 2021
Table 8: Germany Multiple Myeloma Market Trends, 2012 - 2021
Table 9: Marketed Products for Multiple Myeloma in France, 2017
Table 10: France Multiple Myeloma Market Size & Forecast ($mn), 2012 - 2021
Table 11: France Multiple Myeloma Product Sales ($mn), 2012 - 2021
Table 12: France Multiple Myeloma Market Trends, 2012 - 2021
Table 13: Marketed Products for Multiple Myeloma in Italy, 2017
Table 14: Italy Multiple Myeloma Market Size & Forecast ($mn), 2012 - 2021
Table 15: Italy Multiple Myeloma Product Sales ($mn), 2012 - 2021
Table 16: Italy Multiple Myeloma Market Trends, 2012 - 2021
Table 17: Marketed Products for Multiple Myeloma in Spain, 2017
Table 18: Spain Multiple Myeloma Market Size & Forecast ($mn), 2012 - 2021
Table 19: Spain Multiple Myeloma Product Sales ($mn), 2012 - 2021
Table 20: Spain Multiple Myeloma Market Trends, 2012 - 2021
Table 21: Marketed Products for Multiple Myeloma in UK, 2017
Table 22: UK Multiple Myeloma Market Size & Forecast ($mn), 2012 - 2021
Table 23: UK Multiple Myeloma Product Sales ($mn), 2012 - 2021
Table 24: UK Multiple Myeloma Market Trends, 2012 - 2021
Table 25: Europe Multiple Myeloma Market Size & Forecast ($mn), 2012 - 2021
Table 26: Europe Multiple Myeloma Product Sales ($mn), 2012 - 2021

List of Figures:
Figure 1: Multiple Myeloma Pipeline by Phase (%), Global, 2017
Figure 2: Multiple Myeloma Prevalence by EU5 Countries, 2012 - 2021
Figure 3: Germany Multiple Myeloma Market Size ($mn), 2012 - 2021
Figure 4: Germany Multiple Myeloma Product Sales ($mn), 2012 - 2021
Figure 5: Germany Multiple Myeloma Market Share by Products (%), 2016
Figure 6: Germany Multiple Myeloma Market - Future Market Share (%), 2021
Figure 7: France Multiple Myeloma Market Size ($mn), 2012 - 2021
Figure 8: France Multiple Myeloma Product Sales ($mn), 2012 - 2021
Figure 9: France Multiple Myeloma Market Share by Products (%), 2016
Figure 10: France Multiple Myeloma Market - Future Market Share (%), 2021
Figure 11: Italy Multiple Myeloma Market Size ($mn), 2012 - 2021
Figure 12: Italy Multiple Myeloma Product Sales ($mn), 2012 - 2021
Figure 13: Italy Multiple Myeloma Market Share by Products (%), 2016
Figure 14: Italy Multiple Myeloma Market - Future Market Share (%), 2021
Figure 15: Spain Multiple Myeloma Market Size ($mn), 2012 - 2021
Figure 16: Spain Multiple Myeloma Product Sales ($mn), 2012 - 2021
Figure 17: Spain Multiple Myeloma Market Share by Products (%), 2016
Figure 18: Spain Multiple Myeloma Market - Future Market Share (%), 2021
Figure 19: UK Multiple Myeloma Market Size ($mn), 2012 - 2021
Figure 20: UK Multiple Myeloma Product Sales ($mn), 2012 - 2021
Figure 21: UK Multiple Myeloma Market Share by Products (%), 2016
Figure 22: UK Multiple Myeloma Market - Future Market Share (%), 2021
Figure 23: Europe Multiple Myeloma Market Size ($mn), 2012 - 2021
Figure 24: Europe Multiple Myeloma Product Sales ($mn), 2012 - 2021
Figure 25: Europe Multiple Myeloma Market Share by Products (%), 2016
Figure 26: Europe Multiple Myeloma Market - Future Market Share (%), 2021
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll